CVRx, Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 1.425 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 37.96M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Details
| Name | CVRx, Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 223 |
| Founded | 2000 |
| Ipo Date | 2021-06-30 |
| Ceo | Kevin Hykes |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 18.00 |
| Isin | US1266381052 |
| Cusip | 126638105 |
| Cik | 1235912 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Kevin Hykes | President, Chief Executive Officer and Director |
| Dr. Philip B. Adamson M.D., M.Sc. | Chief Medical Officer |
Contact
| Address | 9201 West Broadway Avenue, Suite 650, Minneapolis, Minnesota 55445, United States |
| Phone | 763 416 2840 |
| Website | https://www.barostim.com |